Clinical Trials · NCT01855490
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Yale University
- Enrollment
- 17
- Start date
- Jan 2012
- Locations
- 1 site, United States
- Primary endpoint
- Effect of exenatide on metabolic responses to an oral (as a mixed meal) or intravenous glucose challenge in subjects with established T1D with or without residual insulin production.